Glycol linked fgf-21 compounds

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/50 (2006.01) A61K 38/18 (2006.01) A61P 3/00 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) C07K 17/00 (2006.01)

Patent

CA 2557782

The invention provides FGF-21 compounds covalently attached to at least one polyethylene glycol molecule or derivative thereof, resulting in a biologically active polypeptide with an extended elimination half-life and a slower clearance when compared to that of non-PEGylated polypeptide. These PEGylated FGF-21 compounds and compositions are useful in treating diabetes, obesity, and metabolic syndrome.

La présente invention concerne des composés FGF-21 qui sont liés par covalence à au moins une molécule de polyéthylène glycol ou à un dérivé de ce dernier, ce qui produit un polypeptide biologiquement actif à demi-vie d'élimination étendue et à clairance plus lente comparativement à celles d'un polypeptide non lié au polyéthylène glycol. Ces composés FGF-21 liés au polyéthylène glycol et les compositions correspondantes sont utiles dans le traitement du diabète, de l'obésité et du syndrome métabolique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Glycol linked fgf-21 compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glycol linked fgf-21 compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycol linked fgf-21 compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1349382

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.